|
|
|
Insider
Information: |
Shah Nimish P |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
50,221,732 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$415,597,346 |
|
|
Total
Shares |
50,221,732 |
|
|
Total
Value |
$415,597,346 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
66
|
4
|
Stock
price went up :
|
4
|
0
|
Stock
price went down : |
62
|
4
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
Percentage
Gain/Loss : |
-54.4%
|
-384.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bellerophon Therapeutics Inc |
BLPH |
10% Owner |
2018-08-14 |
0 |
2018-09-17 |
7,386,163 |
Premium* |
|
Kalvista Pharmaceuticals Inc |
KALV |
10% Owner |
2019-03-18 |
0 |
2024-02-08 |
4,824,731 |
Premium* |
|
Constellation Pharmaceuticals Inc |
CNST |
10% Owner |
|
0 |
2019-12-13 |
4,016,873 |
Premium* |
|
Altimmune, Inc |
ALT |
10% Owner |
2020-05-26 |
0 |
2021-02-25 |
3,500,000 |
Premium* |
|
Cogent Biosciences, Inc. |
COGT |
10% Owner |
2020-08-14 |
0 |
2020-08-18 |
4,355,273 |
Premium* |
|
Tricida, Inc. |
TCDA |
10% Owner |
2022-06-02 |
0 |
2022-10-26 |
3,751,406 |
Premium* |
|
Vistagen Therapeutics Inc |
VTGN |
10% Owner |
|
0 |
2022-07-12 |
20,637,286 |
Premium* |
|
Apogee Therapeutics, Inc. |
APGE |
Director |
2023-07-13 |
0 |
2023-07-13 |
1,750,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-06-29 |
4 |
B |
$9.93 |
$164,302 |
I/I |
16,546 |
7,120,121 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-07-29 |
4 |
B |
$9.21 |
$174,069 |
I/I |
18,900 |
7,557,951 |
1.5 |
% |
|
BLPH |
Bellerophon Therapeutics ... |
10% Owner |
|
2018-08-15 |
4 |
B |
$0.65 |
$175,902 |
I/I |
272,000 |
6,474,770 |
1.5 |
- |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-01-03 |
4 |
B |
$12.20 |
$214,781 |
I/I |
17,605 |
4,110,336 |
1.5 |
% |
|
BLPH |
Bellerophon Therapeutics ... |
10% Owner |
|
2018-09-11 |
4 |
B |
$1.14 |
$228,840 |
I/I |
200,000 |
7,101,163 |
1.5 |
- |
|
COGT |
Cogent Biosciences, Inc. |
10% Owner |
|
2020-08-14 |
4 |
B |
$2.30 |
$230,000 |
I/I |
100,000 |
4,004,273 |
1.5 |
- |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-07-19 |
4 |
B |
$9.47 |
$236,750 |
I/I |
25,000 |
7,439,852 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-07-20 |
4 |
B |
$9.54 |
$238,500 |
I/I |
25,000 |
7,464,852 |
1.5 |
% |
|
BLPH |
Bellerophon Therapeutics ... |
10% Owner |
|
2018-09-10 |
4 |
B |
$1.22 |
$243,640 |
I/I |
200,000 |
6,901,163 |
1.5 |
- |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-07-12 |
4 |
B |
$9.81 |
$245,250 |
I/I |
25,000 |
7,245,279 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-01-16 |
4 |
B |
$12.73 |
$249,495 |
I/I |
19,599 |
4,316,046 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-01-24 |
4 |
B |
$12.44 |
$257,334 |
I/I |
20,686 |
4,558,780 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-07-25 |
4 |
B |
$8.95 |
$261,331 |
I/I |
29,199 |
7,539,051 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-01-09 |
4 |
B |
$12.56 |
$261,449 |
I/I |
20,816 |
4,242,100 |
1.5 |
% |
|
COGT |
Cogent Biosciences, Inc. |
10% Owner |
|
2020-08-18 |
4 |
B |
$2.62 |
$264,620 |
I/I |
101,000 |
4,355,273 |
1.5 |
- |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-07-21 |
4 |
B |
$9.59 |
$287,700 |
I/I |
30,000 |
7,494,852 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-10-11 |
4 |
B |
$11.85 |
$296,250 |
I/I |
25,000 |
9,676,114 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-07-05 |
4 |
B |
$9.53 |
$309,725 |
I/I |
32,500 |
7,220,279 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-01-19 |
4 |
B |
$12.43 |
$310,750 |
I/I |
25,000 |
4,459,651 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-07-13 |
4 |
B |
$9.98 |
$327,903 |
I/I |
32,856 |
7,278,135 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-06-28 |
4 |
B |
$9.71 |
$333,694 |
I/I |
34,366 |
7,103,575 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-10-07 |
4 |
B |
$12.00 |
$346,800 |
I/I |
28,900 |
9,570,800 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-06-03 |
4 |
B |
$9.33 |
$351,209 |
I/I |
37,643 |
5,773,654 |
1.5 |
% |
|
TCDA |
Tricida, Inc. |
10% Owner |
|
2022-07-14 |
4 |
B |
$9.85 |
$361,662 |
I/I |
36,717 |
7,314,852 |
1.5 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2024-02-08 |
4 |
B |
$14.70 |
$437,281 |
I/I |
29,747 |
4,824,731 |
1.5 |
% |
|
93 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|